Insights
Kieran Engels writes about the structural patterns that shape clinical development outcomes – and the governance decisions that determine whether programs succeed or fail.
The Age of Accountability resets biotech priorities: clarity of intent, explicit ownership, delivery that matches promise. Speed without control is crash risk. Accountability builds confident acceleration.
Read Article →Clinical catfishing happens when proposals don’t match execution. Align incentives, name teams, and build governance to prevent gaps.
AI-generated proposals are polished but operationally empty. Vendor selection requires specificity and human judgment, not just polish.
The concept of ‘best-fit vendor’ is broken. It relies on surface signals: how polished their pitch is, how available they seem, whether you’ve heard of…